Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Linda Stein Gold MD

Linda Stein Gold MD

Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, Michigan, as well as Division Head of Dermatology at Henry Ford Health System in West Bloomfield, Michigan

Dr. Stein Gold earned her medical degree from the University of Pennsylvania School of Medicine in Philadelphia and completed her residency in dermatology at Henry Ford Hospital.  She is very active in clinical research on a variety of dermatologic conditions, including the treatment of chronic plaque-type psoriasis, actinic keratosis, atopic dermatitis, acne vulgaris, seborrheic dermatitis, and rosacea. She has published articles in journals such as Cutis, the Journal of Drugs in Dermatology, and the Journal of the American Academy of Dermatology, among others. She is a frequent national and international lecturer on psoriasis, alopecia, viral infections, atopic dermatitis, and fungal infections, at grand rounds and medical society meetings. She is also the treasurer of the National Acne and Rosacea Society and a member of the National Psoriasis Foundation Medical Board.

Disclosures

Dr. Stein Gold has relationships with multiple pharmaceutical companies including Leo,Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.

Recent Contributions to PracticeUpdate:

  1. Tapinarof Cream for the Treatment of Plaque Psoriasis: 1-Year Safety and Efficacy
  2. Artificial Intelligence for the Objective Evaluation of Acne
  3. VIDEO: Don’t Discount Topical Therapy for Psoriasis